Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Efficient Rapid Access to Biginelli for the Multicomponent Synthesis of 1,2,3,4-Tetrahydropyrimidines in Room-Temperature Diisopropyl Ethyl Ammonium Acetate.

Jadhav CK, Nipate AS, Chate AV, Songire VD, Patil AP, Gill CH.

ACS Omega. 2019 Dec 17;4(27):22313-22324. doi: 10.1021/acsomega.9b02286. eCollection 2019 Dec 31.

2.

Synthesis and Antitubercular Activity of New Benzo[b]thiophenes.

Mahajan PS, Nikam MD, Nawale LU, Khedkar VM, Sarkar D, Gill CH.

ACS Med Chem Lett. 2016 Jun 28;7(8):751-6. doi: 10.1021/acsmedchemlett.6b00077. eCollection 2016 Aug 11.

3.

The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.

Large CH, Bison S, Sartori I, Read KD, Gozzi A, Quarta D, Antolini M, Hollands E, Gill CH, Gunthorpe MJ, Idris N, Neill JC, Alvaro GS.

J Pharmacol Exp Ther. 2011 Jul;338(1):100-13. doi: 10.1124/jpet.110.178475. Epub 2011 Apr 12.

PMID:
21487071
4.

Development of practical methodologies for the synthesis of novel 3(4-oxo-4H-chromen-3-yl)acrylic acid hydrazides.

Joshi RS, Mandhane PG, Badadhe PV, Gill CH.

Ultrason Sonochem. 2011 May;18(3):735-8. doi: 10.1016/j.ultsonch.2010.11.001. Epub 2010 Nov 11.

PMID:
21112230
5.

Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives.

Joshi RS, Mandhane PG, Diwakar SD, Dabhade SK, Gill CH.

Bioorg Med Chem Lett. 2010 Jun 15;20(12):3721-5. doi: 10.1016/j.bmcl.2010.04.082. Epub 2010 Apr 24.

PMID:
20529688
6.

Ultrasound assisted green synthesis of bis(indol-3-yl)methanes catalyzed by 1-hexenesulphonic acid sodium salt.

Joshi RS, Mandhane PG, Diwakar SD, Gill CH.

Ultrason Sonochem. 2010 Feb;17(2):298-300. doi: 10.1016/j.ultsonch.2009.08.015. Epub 2009 Aug 29.

PMID:
19767231
7.

SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.

Jadhav GR, Shaikh MU, Kale RP, Shiradkar MR, Gill CH.

Eur J Med Chem. 2009 Jul;44(7):2930-5. doi: 10.1016/j.ejmech.2008.12.001. Epub 2008 Dec 16.

PMID:
19150154
8.

Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function.

Holbrook JD, Gill CH, Zebda N, Spencer JP, Leyland R, Rance KH, Trinh H, Balmer G, Kelly FM, Yusaf SP, Courtenay N, Luck J, Rhodes A, Modha S, Moore SE, Sanger GJ, Gunthorpe MJ.

J Neurochem. 2009 Jan;108(2):384-96. doi: 10.1111/j.1471-4159.2008.05775.x. Epub 2008 Nov 29.

9.

Substituted 3-((Z)-2-(4-nitrophenyl)-2-(1H-tetrazol-5-yl) vinyl)-4H-chromen-4-ones as novel anti-MRSA agents: synthesis, SAR, and in-vitro assessment.

Diwakar SD, Bhagwat SS, Shingare MS, Gill CH.

Bioorg Med Chem Lett. 2008 Aug 15;18(16):4678-81. doi: 10.1016/j.bmcl.2008.07.007. Epub 2008 Jul 9.

PMID:
18650090
10.

Inhibition of Ih reduces epileptiform activity in rodent hippocampal slices.

Gill CH, Brown JT, Shivji N, Lappin SC, Farmer C, Randall A, McNaughton NC, Cobb SR, Davies CH.

Synapse. 2006 Apr;59(5):308-16.

PMID:
16421904
11.

Characterization of the human HCN1 channel and its inhibition by capsazepine.

Gill CH, Randall A, Bates SA, Hill K, Owen D, Larkman PM, Cairns W, Yusaf SP, Murdock PR, Strijbos PJ, Powell AJ, Benham CD, Davies CH.

Br J Pharmacol. 2004 Oct;143(3):411-21. Epub 2004 Sep 6.

12.

Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus.

Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH.

Neuropharmacology. 2004 Jun;46(8):1168-76.

PMID:
15111023
13.

Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices of GABAB1 receptor subunit knockout mice.

Brown JT, Gill CH, Farmer CE, Lanneau C, Randall AD, Pangalos MN, Collingridge GL, Davies CH.

Epilepsy Res. 2003 Dec;57(2-3):121-36.

PMID:
15013053
14.

Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist.

Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, Luis Hannan S, Lappin SC, Egerton J, Smith GD, Worby A, Howett L, Owen D, Nasir S, Davies CH, Thompson M, Wyman PA, Randall AD, Davis JB.

Neuropharmacology. 2004 Jan;46(1):133-49. Erratum in: Neuropharmacology. 2004 May;46(6):905.

PMID:
14654105
15.

Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h).

Ray AM, Benham CD, Roberts JC, Gill CH, Lanneau C, Gitterman DP, Harries M, Davis JB, Davies CH.

J Neurosci. 2003 Nov 5;23(31):10146-53.

16.

Activation of Ih is necessary for patterning of mGluR and mAChR induced network activity in the hippocampal CA3 region.

Cobb SR, Larkman PM, Bulters DO, Oliver L, Gill CH, Davies CH.

Neuropharmacology. 2003 Mar;44(3):293-303.

PMID:
12604089
17.

SB-334867-A antagonises orexin mediated excitation in the locus coeruleus.

Soffin EM, Evans ML, Gill CH, Harries MH, Benham CD, Davies CH.

Neuropharmacology. 2002 Jan;42(1):127-33.

PMID:
11750922
18.

5-HT7 receptors modulate synchronized network activity in rat hippocampus.

Gill CH, Soffin EM, Hagan JJ, Davies CH.

Neuropharmacology. 2002 Jan;42(1):82-92.

PMID:
11750918
19.

Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice.

Prosser HM, Gill CH, Hirst WD, Grau E, Robbins M, Calver A, Soffin EM, Farmer CE, Lanneau C, Gray J, Schenck E, Warmerdam BS, Clapham C, Reavill C, Rogers DC, Stean T, Upton N, Humphreys K, Randall A, Geppert M, Davies CH, Pangalos MN.

Mol Cell Neurosci. 2001 Jun;17(6):1059-70.

PMID:
11414794
20.
21.

Regulation of depolarizing GABA(A) receptor-mediated synaptic potentials by synaptic activation of GABA(B) autoreceptors in the rat hippocampus.

Cobb SR, Manuel NA, Morton RA, Gill CH, Collingridge GL, Davies CH.

Neuropharmacology. 1999 Nov;38(11):1723-32.

PMID:
10587088
22.
23.

The child, his parents and the illness.

Gill CH.

Practitioner. 1983 Feb;227(1376):191-4. No abstract available.

PMID:
6866909

Supplemental Content

Support Center